# The Von Willebrand Disease (VWD) International Prophylaxis Study

> **NCT00557908** · — · COMPLETED · sponsor: **Skane University Hospital** · enrollment: 105 (actual)

## Conditions studied

- Von Willebrand Disease

## Interventions

- **DRUG:** VWF/FVIII products

## Key facts

- **NCT ID:** NCT00557908
- **Lead sponsor:** Skane University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2017-10-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00557908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00557908, "The Von Willebrand Disease (VWD) International Prophylaxis Study". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00557908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*